Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W F Benedict

Showing results (61-70 of 157) with videos related to

Pageof 16
Sort By:
Birth Defects Original Article Series|January 1, 1982
Recent developments in the genetics and treatment of retinoblastomaA L Murphree, C J Gomer, D R Doiron, et al.
Biochemical and Biophysical Research Communications|February 4, 1974
Aryl hydrocarcon hydroxylase and tyrosine aminotransferase activities in somatic-cell hybrids derived from hepatoma tissue culture HTC (rat) cells and 3T3 (mouse) benzo(a)pyrene-resistant cellsE B Thompson, W F Benedict, I S Owens, et al.
Cancer Research|September 1, 1975
1-beta-D-arabinofuranosylcytosine-induced malignant transformation of hamster and rat cells in cultureR E Kouri, S A Kurtz, P J Price, et al.
Biochemical and Biophysical Research Communications|January 12, 1976
The effect of cyclic AMP and prostaglandins on the fibrinolytic activity of mouse neuroblastoma cellsW E Laug, P A Jones, C A Nye, et al.
Cancer Research|July 1, 1977
Cell cycle-specific oncogenic transformation of C3H/10T1/2 clone 8 mouse embryo cells by 1-beta-D-arabinofuranosylcytosineP A Jones, M S Baker, J S Bertram, et al.
Investigative Ophthalmology & Visual Science|January 1, 1982
Tissue distribution of 3H-hematoporphyrin derivative in athymic "nude" mice heterotransplanted with human retinoblastomaC J Gomer, N Rucker, C Mark, et al.
Human Genetics|May 1, 1987
A null allele of esterase D is a marker for genetic events in retinoblastoma formationW H Lee, R Bookstein, W Wheatley, et al.
Cancer Research|April 15, 1995
Frequent loss of heterozygosity at the retinoblastoma susceptibility gene (RB) locus in aggressive pituitary tumors: evidence for a chromosome 13 tumor suppressor gene other than RBL Pei, S Melmed, B Scheithauer, et al.
Cancer Research|July 1, 1977
Mutagenicity of cancer chemotherapeutic agents in the Salmonella/microsome testW F Benedict, M S Baker, L Haroun, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1997
Mantle cell lymphoma: correlation of clinical outcome and biologic features with three histologic variantsA Majlis, W C Pugh, M A Rodriguez, et al.
Pageof 16

Showing results (61-70 of 157) with videos related to

Sort By:
Pageof 16
Birth Defects Original Article Series|January 1, 1982
Recent developments in the genetics and treatment of retinoblastomaA L Murphree, C J Gomer, D R Doiron, et al.
Biochemical and Biophysical Research Communications|February 4, 1974
Aryl hydrocarcon hydroxylase and tyrosine aminotransferase activities in somatic-cell hybrids derived from hepatoma tissue culture HTC (rat) cells and 3T3 (mouse) benzo(a)pyrene-resistant cellsE B Thompson, W F Benedict, I S Owens, et al.
Cancer Research|September 1, 1975
1-beta-D-arabinofuranosylcytosine-induced malignant transformation of hamster and rat cells in cultureR E Kouri, S A Kurtz, P J Price, et al.
Biochemical and Biophysical Research Communications|January 12, 1976
The effect of cyclic AMP and prostaglandins on the fibrinolytic activity of mouse neuroblastoma cellsW E Laug, P A Jones, C A Nye, et al.
Cancer Research|July 1, 1977
Cell cycle-specific oncogenic transformation of C3H/10T1/2 clone 8 mouse embryo cells by 1-beta-D-arabinofuranosylcytosineP A Jones, M S Baker, J S Bertram, et al.
Investigative Ophthalmology & Visual Science|January 1, 1982
Tissue distribution of 3H-hematoporphyrin derivative in athymic "nude" mice heterotransplanted with human retinoblastomaC J Gomer, N Rucker, C Mark, et al.
Human Genetics|May 1, 1987
A null allele of esterase D is a marker for genetic events in retinoblastoma formationW H Lee, R Bookstein, W Wheatley, et al.
Cancer Research|April 15, 1995
Frequent loss of heterozygosity at the retinoblastoma susceptibility gene (RB) locus in aggressive pituitary tumors: evidence for a chromosome 13 tumor suppressor gene other than RBL Pei, S Melmed, B Scheithauer, et al.
Cancer Research|July 1, 1977
Mutagenicity of cancer chemotherapeutic agents in the Salmonella/microsome testW F Benedict, M S Baker, L Haroun, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1997
Mantle cell lymphoma: correlation of clinical outcome and biologic features with three histologic variantsA Majlis, W C Pugh, M A Rodriguez, et al.
Pageof 16